Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) hit a new 52-week high during mid-day trading on Friday. The company traded as high as $53.25 and last traded at $53.25, with a volume of 750 shares changing hands. The stock had previously closed at $50.93.
Orion OYJ Price Performance
The company has a fifty day simple moving average of $46.50 and a 200 day simple moving average of $41.80. The stock has a market capitalization of $15.03 billion, a price-to-earnings ratio of 21.91 and a beta of 0.07. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64.
About Orion OYJ
Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.
The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.
Founded in Finland in 1917, Orion is headquartered in Espoo.
Further Reading
- Five stocks we like better than Orion OYJ
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
